Move for Change Part I: A European survey evaluating the impact of the EPDA Charter for People with Parkinson's disease

European Journal of Neurology

Volumn 19, Issue 3, 2012, Pages 402-410

  Bloem, B R ^a   Stocchi, F ^b  

^a RADBOUD UNIVERSITY   (Netherlands)

^b IRCCS SAN RAFFAELE PISANA   (Italy)

Author keywords

Charter; Diagnosis; EPDA; European survey; Guidelines; Parkinson's disease; Quality of care; Treatment

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL EVALUATION; EUROPE; FEMALE; GENERAL PRACTITIONER; HEALTH CARE DELIVERY; HEALTH CARE POLICY; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL SPECIALIST; NEUROLOGIST; PARKINSON DISEASE; PATIENT CARE; PRIORITY JOURNAL;

AGED; AGED, 80 AND OVER; DATA COLLECTION; DELIVERY OF HEALTH CARE; EUROPE; FEMALE; HUMANS; MALE; MIDDLE AGED; PARKINSON DISEASE; STANDARD OF CARE;

EID: 84857050033     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/j.1468-1331.2011.03532.x     Document Type: Article

References (49)

1. Bekris LM, Mata IF, Zabetian CP. The genetics of Parkinson disease. J Geriatr Psychiatry Neurol 2010; 23: 228-242.
2. Chaudhuri KR, Healy DG, Schapira AH, National Institute for Clinical Excellence. Non-motor symptoms of Parkinson's disease: diagnosis and management. Lancet Neurol 2006; 5: 235-245.
3. Harrower TP, Michell AW, Barker RA. Lewy bodies in Parkinson's disease: protectors or perpetrators? Exp Neurol 2005; 195: 1-6.
4. Van Den Eeden SK, Tanner CM, Bernstein AL, et al. Incidence of Parkinson's disease: variation by age, gender, and race/ethnicity. Am J Epidemiol 2003; 157: 1015-1022.
5. Andlin-Sobocki P, Jönsson B, Wittchen HU, Olesen J. Cost of disorders of the brain in Europe. Eur J Neurol 2005; 12(Suppl. 1): 1-27.
6. Lindgren P. Economic evidence in Parkinson's disease: a review. Eur J Health Econ 2004; 49(Suppl. 1): S62-S65.
7. Schrag A, Schott JM. Epidemiological, clinical and genetic characteristics of early-onset parkinsonism. Lancet Neurol 2006; 5: 355-363.
8. Wickremaratchi MM, Perera D, O'Loghlen C, et al. Prevalence and age of onset of Parkinson's disease in Cardiff: a community based cross sectional study and meta-analysis. J Neurol Neurosurg Psychiatry 2009; 80: 805-807.
9. Jankovic J. Parkinson's disease: clinical features and diagnosis. J Neurol Neurosurg Psychiatry 2008; 7: 368-376.
10. Schapira AH, Aqid Y, Barone P, et al. Perspectives on recent advances in the understanding and treatment of Parkinson's disease. Eur J Neurol 2009; 16: 1090-1099.
11. Chaudhuri KR, Schapira AH. Non-motor symptoms of Parkinson's disease: dopaminergic pathophysiology and treatment. Lancet Neurol 2009; 8: 464-474.
12. Visser M, van Rooden SM, Verbaan D, Marinus J, Stiggelbout AM, van Hilten JJ. A comprehensive model of health-related quality of life in Parkinson's disease. J Neurol 2008; 255: 1580-1587.
13. Muzerengi S, Contrafatto D, Chaudhuri KR. Non-motor symptoms: identification and management. Parkinsonism Relat Disord 2007; 13(Suppl. 3): S450-S456.
14. Politis M, Wu K, Molloy S, G Bain P, Chaudhuri KR, Piccini P. Parkinson's disease symptoms: the patient's perspective. Mov Disord 2010; 25: 1646-1651.
15. Lindgren P, von Campenhausen S, Spottke E, Siebert U, Dodel R. Cost of Parkinson's disease in Europe. Eur J Neurol 2005; 12(Suppl. 1): 68-73.
16. Winter Y, von Campenhausen S, Brozova H, et al. Costs of Parkinson's disease in Eastern Europe: a Czech cohort study. Parkinsonism Relat Disord 2010; 16: 51-56.
17. Jennum P, Zoetmulder M, Korbo L, Kjellberg J. The health-related, social, and economic consequences of parkinsonism: a controlled national study. J Neurol 2011; DOI
18. Post B, van der Eijk M, Munneke M, Bloem BR. Multidisciplinary care for Parkinson's disease: not if, but how! Pract Neurol 2011; 11: 58-61.
19. van der Eijk M, Faber MJ, Al Shamma S, Munneke M, Bloem BR. Moving towards patient-centered healthcare for patients with Parkinson's disease. Parkinsonism Relat Disord 2011; 17: 360-364.
20. European Parkinson's Disease Association (EPDA). EPDA Charter. (accessed 16/06/2011).
21. Baker M, Graham L. The journey: Parkinson's disease. Br Med J 2004; 329: 611-614.
22. Kale R, Menken M. Who should look after people with Parkinson's disease? Multidisciplinary teams are needed to address the needs of patients. Br Med J 2004; 328: 62-63.
23. European Pharmaceutical Market Research Association (EphMRA). Code of Conduct 2011. (accessed 16/06/2011).
24. National Patient Safety Agency. Defining Research. NRES guidance to help you decide if your project requires review by a Research Ethics Committee. 2010, (accessed 16/06/2011).
25. Scottish Intercollegiate Guidelines Network (SIGN). 113 Diagnosis and pharmacological management of Parkinson's disease. A national clinical guideline. 2010, (accessed 16/06/2011).
26. National Collaborating Centre for Chronic Conditions (NCCCC). Parkinson's disease. National clinical guideline for diagnosis and management in primary and secondary care. 2006, (accessed 16/06/2011).
27. Horstink M, Tolosa E, Bonuccelli U, et al. Review of the therapeutic management of Parkinson's disease. Report of a joint task force of the European Federation of Neurological Societies and the Movement Disorder Society - European Section. Part I: early (uncomplicated) Parkinson's disease. Eur J Neurol 2006; 13: 1170-1185.
28. Horstink M, Tolosa E, Bonuccelli U, et al. Review of the therapeutic management of Parkinson's disease. Report of a joint task force of the European Federation of Neurological Societies (EFNS) and the Movement Disorder Society - European Section (MDS-ES). Part II: late (complicated) Parkinson's disease. Eur J Neurol 2006; 13: 1186-1202.
29. Van Rooden SM, Colas F, Martínez-Martín P, et al. Clinical subtypes of Parkinson's disease. Mov Disord 2011; 26: 51-58.
30. Bloem BR, Van Laar T, Keus SHJ, et al. Multidisciplinaire richtlijn 'Ziekte van Parkinson'. Alphen aan den Rijn: Van Zuiden Communications B.V, 2010.
31. Schrag A, Ben-Shlomo Y, Quinn N. How valid is the clinical diagnosis of Parkinson's disease in the community? J Neurol Neurosurg Psychiatry 2002; 73: 529-534.
32. Leifer BP. Early diagnosis of Alzheimer's Disease: clinical and economic benefits. J Am Geriatr Soc 2003; 51: S281-S288.
33. Chen JJ. Parkinson's disease: health-related quality of life, economic cost, and implications of early treatment. Am J Manag Care 2010; 16: S87-S93.
34. Akbari A, Mayhew A, Al-Alawi MA, et al. Interventions to improve outpatient referrals from primary care to secondary care (review). Cochrane Database Syst Rev 2008; 4: CD005471.
35. Ghosh R, Liddle BJ. Emergency presentations of Parkinson's disease: early recognition and treatment are crucial for optimum outcome. Postgrad Med J 2011; 87: 125-131.
36. Cheng EM, Swarztrauber K, Siderowf AD, et al. Association of specialist involvement and quality of care for Parkinson's disease. Mov Disord 2007; 22: 515-522.
37. Dorsey ER, Deuel LM, Voss TS, et al. Increasing access to specialty care: a pilot, randomized controlled trial of telemedicine for Parkinson's disease. Mov Disord 2010; 25: 1652-1659.
38. Horner RD, Matchar DB, Divine GW, Feussner JR. Relationship between physician specialty and the selection and the outcome of ischemic stroke patients. Health Serv Res 1995; 30: 275-287.
39. Vickrey BG, Edmonds ZV, Shatin D, et al. General neurologist and subspecialist care for multiple sclerosis: patients' perceptions. Neurology 1999; 53: 1190-1197.
40. Sieber WJ, Kaplan RM. Informed adherence: the need for shared medical decision making. Control Clin Trials 2000; 21: 233S-240S.
41. van Peperstraten A, Nelen W, Grol R, et al. The effect of a multifaceted empowerment strategy on decision making about the number of embryos transferred in in vitro fertilisation: randomised controlled trial. Br Med J 2010; 340: c2501.
42. Wilson SR, Strub P, Buist AS, et al. Shared treatment decision-making improves adherence and outcomes in poorly controlled asthma. Am J Respir Crit Care Med 2010; 181: 566-577.
43. Vermeire W, Hearnshaw H, van Royen P, Denekens J. Patient adherence to treatment: three decades of research. A comprehensive review. J Clin Pharm Ther 2001; 26: 331-342.
44. Hubble JP, Pahwa R, Michalek DK, Thomas C, Koller WC. Interactive video conferencing: a means of providing interim care to Parkinson's disease patients. Mov Disord 1993; 8: 380-382.
45. Hopley M, Horsburgh M, Peri K. Barriers to accessing specialist care for older people with chronic obstructive pulmonary disease in rural New Zealand. J Prim Health Care 2009; 1: 207-214.
46. Fortin M, Maltais D, Hudon C, Lapointe L, Ntetu AL. Access to health care: perceptions of patients with multiple chronic conditions. Can Fam Physician 2004; 51: 1502-1503.
47. Global Parkinson's Disease Survey Steering Committee (GPDSSC). Factors impacting on quality of life in Parkinson's disease: results from an international survey. Mov Disord 2002; 17: 60-67.
48. Wilkins AS. Expanding Internet access for health care consumers. Health Care Manage Rev 1999; 24: 30-41.
49. Ritter P, Lorig K, Laurent D, Matthews K. Internet versus mailed questionnaires: a randomized comparison. J Med Internet Res 2004; 6: e29.